Clinical Trial Update: Use of Topical Solasodine of Solanum Melongena Peel Origin in the Treatment of Palmar Arsenic Keratosis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating topical solasodine from Solanum melongena peel for palmar arsenic keratosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmar Arsenic Keratosis

Drugs mentioned

• topical solasodine from Solanum melongena peel (solasodine)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Keratotic Nodular Size | Phase 2 | Status: UNKNOWN